- Home
- SAVA vs LFVN Comparison
SAVA vs LFVN Comparison
Compare SAVA & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- LFVN
- Stock Information
- Founded
- SAVA 1998
- LFVN N/A
- Country
- SAVA United States
- LFVN United States
- Employees
- SAVA N/A
- LFVN N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- SAVA Health Care
- LFVN Health Care
- Exchange
- SAVA Nasdaq
- LFVN Nasdaq
- Market Cap
- SAVA 157.5M
- LFVN 145.2M
- IPO Year
- SAVA N/A
- LFVN N/A
- Fundamental
- Price
- SAVA $2.82
- LFVN $6.55
- Analyst Decision
- SAVA Buy
- LFVN Strong Buy
- Analyst Count
- SAVA 2
- LFVN 2
- Target Price
- SAVA $5.00
- LFVN $30.50
- AVG Volume (30 Days)
- SAVA 1.2M
- LFVN 192.4K
- Earning Date
- SAVA 11-12-2025
- LFVN 11-04-2025
- Dividend Yield
- SAVA N/A
- LFVN 2.78%
- EPS Growth
- SAVA N/A
- LFVN 143.91
- EPS
- SAVA N/A
- LFVN 0.78
- Revenue
- SAVA N/A
- LFVN $228,877,000.00
- Revenue This Year
- SAVA N/A
- LFVN $6.93
- Revenue Next Year
- SAVA N/A
- LFVN $1.43
- P/E Ratio
- SAVA N/A
- LFVN $8.31
- Revenue Growth
- SAVA N/A
- LFVN 16.77
- 52 Week Low
- SAVA $1.15
- LFVN $5.98
- 52 Week High
- SAVA $33.98
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- SAVA 38.79
- LFVN 32.52
- Support Level
- SAVA $2.65
- LFVN $5.98
- Resistance Level
- SAVA $3.30
- LFVN $7.47
- Average True Range (ATR)
- SAVA 0.21
- LFVN 0.55
- MACD
- SAVA -0.07
- LFVN -0.01
- Stochastic Oscillator
- SAVA 18.02
- LFVN 23.26
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.